ischemic stroke
Conditions
Interventions
control group:Placebo-controlled treatment
electroacupuncture group:electroacupuncture (EA)
Sponsors
Xiyuan Hospital China Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Comply with the diagnostic criteria of acute ischemic stroke and the diagnostic criteria of stasis-toxicity syndrome in the China Acute Ischemic Stroke Diagnostic Guidelines 2023 (2) First onset of disease; (3) Duration of the disease: =7 days; (4) NIHSS score: =15 points. (5) Age between 18 and 80 years old; (6) GCS score =9; (7) Voluntary and signed informed consent. (8) Right-handed patients; (9) The vessel responsible for the infarct focus was the left middle cerebral artery blood-supplying area.
Exclusion criteria
Exclusion criteria: (1) Patients who are eligible for thrombolysis/thrombolysis and are ready to receive thrombolysis/thrombolysis or have already received thrombolysis/thrombolysis; (2) Patients who cannot receive electroacupuncture treatment due to the presence of needle-sickness blood-sickness etc.; (3) Patients with severe skin ulcers or skin diseases who cannot receive acupuncture treatment; (4) Patients with severe combined circulatory respiratory urinary digestive diseases and cancer and those with other organic lesions (e.g. brain tumors) detected in MRI scans; (5) Patients with a history of mental retardation mobility impairment cognitive impairment or other conditions that would limit the validity of informed consent for participation in this study or the evaluation of treatment; and (5) Patients with a history of mental illness intellectual disability mobility problems aphasia cognitive impairment or other conditions that would limit the validity of their informed consent to participate in the study or the efficacy of the study; (6) Patients who have been treated with blood-activating and detoxifying herbal medicines within 2 weeks or those who have participated in other clinical trials in the past 3 months or those who are unable to comply with the study protocol; (7) Pregnant or breastfeeding women or women who have been preparing for pregnancy in the near future (7) Pregnant or lactating women or women who have recently prepared for pregnancy; (8) Those who have been clinically assessed as unsuitable to participate in the clinical trial. (9) Those who have claustrophobia or other contraindications to MRI such as the presence of metal in the body (e.g. cardiac stents interventions dentures etc.) or those who are unable to cooperate with the MRI;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Assessment scale (FMA);National Institute of Health Stroke Scale( NIHSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| Modified Barthel Index(MBI);Chinese Medicine Symptom Observation Chart;Modified Rankin Scale(mRS);Activity of Daily Living(ADL); | — |
Countries
China
Contacts
Public ContactYunling Zhang
Xiyuan Hospital China Academy of Traditional Chinese Medicine
Outcome results
None listed